A group of researchers have unraveled a new strategy to alter glucagon receptor signaling in the liver by changing its intracellular trafficking. Glucagon is a peptide hormone, that is responsible for glucose balance and thus the regulation of blood glucose levels. The novel approach offers therapeutic potential for the treatment of type 2 diabetes by uncoupling glucagon’s glucose and lipid metabolism-related effects.
During fasting, the hormone glucagon circulates through the body to initiate the release and breakdown of stored glucose and lipids from the liver to provide energy. Whether and how the usage of the two energy sources (glucose and lipids) can be activated independently was not known to date. A study has now identified that depleting the protein Vps37a from the liver alters the localization of the glucagon receptor within the cell, thereby allowing distinct activation of glucose metabolism on intracellular membranes without affecting lipids.
The liver is the main organ required for maintaining balanced blood glucose levels during fasting by releasing stored glucose upon external signals, such as glucagon. In type 2 diabetes, however, this pathway becomes overactivated, leading to glucose production from the liver despite already high blood glucose levels. This condition of too high glucose levels in the blood is called hyperglycemia. Pharmacological inhibition of glucagon action in the liver has been proven to be challenging, as glucagon is not only regulating glucose production but also mediating liver lipid breakdown. Therefore, blocking glucagon action bears lipid accumulation in the liver as negative side effect.
The team of researchers has now found a possible way to disconnect the two pathways, by interfering with the intracellular location and signaling pathways of glucagon receptor, thereby reviving glucagon antagonism as potential treatment for type 2 diabetes.
Obesity and associated type 2 diabetes prevalences are strongly increasing. However, as not every patient is responding equally well to already existing therapies, more treatment options are required. The study expands the current treatment horizon by offering an elegant way to make use of effective blood glucose reduction through glucagon inhibition without lipid-related side effects.
https://www.cell.com/cell-metabolism/fulltext/S1550-4131(22)00412-0
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fvps37a-regulates&filter=22
Glucagon receptor localization regulates its metabolic signaling in the liver
- 1,191 views
- Added
Edited
Latest News
Therapeutic avenues in bone…
By newseditor
Posted 23 May
Linking key nutrients with…
By newseditor
Posted 23 May
Ferroptosis in fatal COVID-…
By newseditor
Posted 22 May
Grid cell-like representati…
By newseditor
Posted 22 May
Cellular mechanisms underly…
By newseditor
Posted 22 May
Other Top Stories
A key protein linked to ageing identified
Read more
Vasomotion is critical in clearing amyloid from the brain
Read more
Using health records and not genetic data to calculate genetic link…
Read more
Tau and amyloid team up to damage synapses!
Read more
Neurons regulating early alcohol consumption identified!
Read more
Protocols
Efficient expansion and CRI…
By newseditor
Posted 21 May
Massively parallel in vivo…
By newseditor
Posted 20 May
Breast cancer-on-chip for p…
By newseditor
Posted 16 May
Methods for making and obse…
By newseditor
Posted 15 May
Mime-seq 2.0: a method to s…
By newseditor
Posted 13 May
Publications
Therapeutic avenues in bone…
By newseditor
Posted 23 May
Investigating nutrient biom…
By newseditor
Posted 23 May
Fatal COVID-19 pulmonary di…
By newseditor
Posted 22 May
GABA co-released from stria…
By newseditor
Posted 22 May
The IL-33/ST2 axis is prote…
By newseditor
Posted 22 May
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar